The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Drug‐induced phospholipidosis
Abstract
Drug‐induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. Organs affected by phospholipidosis exhibit inflammatory reactions and histopathological changes. Despite significant advances in the understanding of drug‐altered lipid metabolism, the relationship between impaired phospholipid metabolism and drug‐induced toxicity remains enigmatic. Here we review molecular features of inheritable lysosomal storage disorders as a molecular mimicry of drug‐induced phospholipidosis for an improved understanding of adverse drug reaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033 · cited 1×
“The lysosome is part of the endosomal–lysosomal system, which was first discovered by Cristian De Duve in 1955 [16].”
BackgroundDeath by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,364
Aminoglycosides: Activity and Resistance
Mingeot-Leclercq, M.-P., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,113
The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages
Feng, B., Yao, P. M., Li, Y., Devlin, C. M., Zhang, D., Harding, H. P., Sweeney, M., Rong, J. X., Kuriakose, G., Fisher, E. A., et al. (2003) · Nature Cell Biology · doi:10.1038/ncb1035 · Cited by 885
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Aminoglycosides: Nephrotoxicity
Mingeot-Leclercq, M.-P., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1003 · Cited by 757
At the acidic edge: emerging functions for lysosomal membrane proteins
Eskelinen, E.-L., Tanaka, Y., & Saftig, P. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00005-9 · Cited by 660
Cholesterol Sensing, Trafficking, and Esterification
Chang, T.-Y., Chang, C. C. Y., Ohgami, N., & Yamauchi, Y. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104656 · Cited by 633
Kolter, T., & Sandhoff, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120013 · Cited by 464
Cited by
The influence of lipophilicity in drug discovery and design
Arnott, J. A., & Planey, S. L. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.714363 · Cited by 868
Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity
Stern, S. T., Adiseshaiah, P. P., & Crist, R. M. (2012) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-9-20 · Cited by 836
Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System
Thoolen, B., Maronpot, R. R., Harada, T., Nyska, A., Rousseaux, C., Nolte, T., Malarkey, D. E., Kaufmann, W., Küttler, K., Deschl, U., et al. (2010) · Toxicologic Pathology · doi:10.1177/0192623310386499 · Cited by 631
Meanwell, N. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200211v · Cited by 620
Nanotechnology Safety Concerns Revisited
Stern, S. T., & McNeil, S. E. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm169 · Cited by 560
Metadata
- Authors
- Anderson, N., & Borlak, J.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2006-09-05
- Volume
- 580
- Issue
- 23
- Pages
- 5533-5540
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2077732560
- Cited by
- 346
- References
- 47
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug‐induced phospholipidosis. https://app.cochat.ai/papers/10.1016/j.febslet.2006.08.061
- The paper
- Anderson, N., & Borlak, J. (2006). Drug‐induced phospholipidosis. FEBS Letters. https://doi.org/10.1016/j.febslet.2006.08.061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.